Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United States — Biomedical Advanced Research and Development Authority

Tracked across 7 events · 642 articles · First seen May 29, 2025 · Last active Aug 07, 2026

Sentiment
4
Attention
8
Events
7
Relationships
8
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Business
Impact: The United States — Biomedical Advanced Research and Development Authority>>> awarded USD 13.3 million to Basilea Pharmaceutica>>> to support the development of a novel antibiotic, demonstrating its commitment to addressing public health needs related to multidrug-resistant infections.
May 27, 2026 · 7 articles
2 0
Business
Impact: BARDA awarded additional funding to Basilea under an existing OTA, supporting development of novel antifungal agents.
Jul 29, 2026 · 6 articles
8 50
Accidents
Impact: The United States — Biomedical Advanced Research and Development Authority has backed the development of MBP134 and is coordinating shipments of the investigational treatment for potential use in high-risk Americans.
May 18, 2026 · 505 articles
3 0
Regulatory
Impact: BARDA funded the development of the test under a 2022 contract, supporting pandemic preparedness.
Jul 21, 2026 · 6 articles
7 -20
Regulatory
On August 5, 2026, the U.S. United States — Food and Drug Administration (FDA) approved Moderna's mFLUSIVA (mRNA-1010), the first mRNA-based seasonal influenza vaccine, for adults aged 50 and older. The approval covers traditional approval…
Impact: BARDA's mRNA vaccine development activities were wound down by HHS, reducing federal support for mRNA technology. This approval may partially offset that setback.
Aug 05, 2026 · 105 articles
4 0
Tech
May 12, 2026 · 6 articles
2 0
Business
Apr 28, 2026 · 7 articles
United States — United States Department of Health and Human Services United States — Biomedical Advanced Research and Development Authority
United States — United States Department of Health and Human Services United States — Biomedical Advanced Research and Development Authority
United States — National Institutes of Health United States — Biomedical Advanced Research and Development Authority
United States — National Institutes of Health United States — Biomedical Advanced Research and Development Authority
United States — Food and Drug Administration United States — Biomedical Advanced Research and Development Authority
United States — Food and Drug Administration United States — Biomedical Advanced Research and Development Authority
United States United States — Biomedical Advanced Research and Development Authority
United States United States — Biomedical Advanced Research and Development Authority
ERGEN INTELLIGENCE
Track United States — Biomedical Advanced Research and Development Authority live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.